Product Information
GNP MUCUS DM ER 600-30 MG TAB is a generic product labeled by AmerisourceBergen, priced at $0.3560 per EA under NDC 46122081761. Its NADAC has been published 42 times since Dec 17, 2025.
FDA first approved this application on Mar 5, 2018.
Strength
30; 600 mg/1; mg/1
Manufacturer
AmerisourceBergenNDC
46122081761
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
Generic (ANDA)
FDA Application
ANDA207602FDA Approved
3/5/2018
On Market Since
9/12/2025
Pharmacological Classes
Price Statistics
The NADAC for GNP MUCUS DM ER 600-30 MG TAB has been published 42 times since Dec 17, 2025, and over the history we have for it it has declined 5.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3560 per EA |
|---|---|
| All-time high | $0.3940 (Jun 10, 2026) |
| All-time low | $0.3481 (Feb 18, 2026) |
| 52-week high | $0.3940 |
| 52-week low | $0.3481 |
| Median price | $0.3643 |
| Average price | $0.3703 |
| Largest weekly change | -6.9% (Jan 21, 2026) |
| Weeks tracked | 42 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dextromethorphan hydrobromide, guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP MUCUS DM ER 600-30 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for GNP MUCUS DM ER 600-30 MG TAB, manufactured by AmerisourceBergen, is $0.3560 per EA (NDC 46122081761), effective Sep 30, 2026.
How has the price of GNP MUCUS DM ER 600-30 MG TAB changed over time?
Over the history we have for it, the NADAC for GNP MUCUS DM ER 600-30 MG TAB has declined 5.7%. It has been tracked across 42 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for GNP MUCUS DM ER 600-30 MG TAB?
Since Dec 17, 2025, the NADAC for GNP MUCUS DM ER 600-30 MG TAB has ranged from a low of $0.3481 (Feb 18, 2026) to a high of $0.3940 (Jun 10, 2026), with a median of $0.3643 per EA.
Are there cheaper alternatives to GNP MUCUS DM ER 600-30 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GNP MUCUS DM ER 600-30 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures GNP MUCUS DM ER 600-30 MG TAB?
GNP MUCUS DM ER 600-30 MG TAB (NDC 46122081761) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.